skip-to-main

Spikevax XBB.1.5 0.1 mg/mL dispersion for injection

Spikevax XBB.1.5 50 micrograms dispersion for injection

Spikevax XBB.1.5 50 micrograms dispersion for injection in pre-filled syringe

Patient Information Leaflet

Summary of Product Characteristics

Spikevax bivalent Original/Omicron BA.4-5 (50 micrograms/50 micrograms)/mL dispersion for injection

Spikevax bivalent Original/Omicron BA.4-5 25 micrograms/25 micrograms dispersion for injection

Spikevax bivalent Original/Omicron BA.4-5 25 micrograms/25 micrograms dispersion for injection in pre-filled syringe

Patient Information Leaflet

Summary of Product Characteristics

Spikevax bivalent Original/Omicron BA.1 (50 micrograms/50 micrograms)/mL dispersion for injection

Spikevax bivalent Original/Omicron BA.1 25 micrograms/25 micrograms dispersion for injection

Spikevax bivalent Original/Omicron BA.1 25 micrograms/25 micrograms dispersion for injection in pre-filled syringe

Patient Information Leaflet

Summary of Product Characteristics

Direct Healthcare Professional Communication

Spikevax (previously COVID‑19 Vaccine Moderna)

Spikevax is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older.

Patient Information Leaflet

Summary of Product Characteristics

Tools

Temperature Excursion Tool

See what to do with vials of the Moderna COVID-19 Vaccine that may have experienced a temperature excursion prior to administering.

Contact Moderna

8am-5pm CET – Mon - Fri
EMEAMedinfo@modernatx.com

    © 2024 Moderna, Inc.

    MT-COV-2100001 10/2023